These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20060467)

  • 61. Characterisation and fundamental insight into the formation of new solid state, multicomponent systems of propranolol.
    Bialek K; Wojnarowska Z; Twamley B; Tajber L
    Int J Pharm; 2021 Jun; 602():120605. PubMed ID: 33862135
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Microenvironmental pH Modification in Buccal/Sublingual Dosage Forms for Systemic Drug Delivery.
    He S; Mu H
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839959
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical pharmacokinetic study of latrepirdine via in silico sublingual administration.
    Santos J; Lobato L; Vale N
    In Silico Pharmacol; 2021; 9(1):29. PubMed ID: 33898159
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Influence of the p
    Hu Y; Guo Y; Li B; Xu R; Fang X; Cao Y; Liu Z; Jiang C; Lu S
    ACS Omega; 2021 Feb; 6(4):3106-3119. PubMed ID: 33553927
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical pharmacokinetics of buffered propranolol sublingual tablet (Promptol™)-application of a new "physiologically based" model to assess absorption and disposition.
    Wang Y; Wang Z; Zuo Z; Tomlinson B; Lee BT; Bolger MB; Chow MS
    AAPS J; 2013 Jul; 15(3):787-96. PubMed ID: 23605805
    [TBL] [Abstract][Full Text] [Related]  

  • 66. HO-1-u-1 model for screening sublingual drug delivery--influence of pH, osmolarity and permeation enhancer.
    Wang Y; Zuo Z; Chow MS
    Int J Pharm; 2009 Mar; 370(1-2):68-74. PubMed ID: 19071203
    [TBL] [Abstract][Full Text] [Related]  

  • 67. In silico model of drug permeability across sublingual mucosa.
    Goswami T; Kokate A; Jasti BR; Li X
    Arch Oral Biol; 2013 May; 58(5):545-51. PubMed ID: 23123066
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Is epinephrine administration by sublingual tablet feasible for the first-aid treatment of anaphylaxis? A proof-of-concept study.
    Gu X; Simons KJ; Simons FE
    Biopharm Drug Dispos; 2002 Jul; 23(5):213-6. PubMed ID: 12116053
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Preparation and evaluation of a novel delayed-onset sustained-release system of propranolol hydrochloride.
    Feng XM; Ren Q; Zhang WZ; Shen HF; Rong ZX; Fang C; Chen HZ
    J Pharm Pharmacol; 2008 Jul; 60(7):817-22. PubMed ID: 18549667
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Improving sublingual delivery of weak base compounds using pH(max) concept: application to propranolol.
    Wang Y; Zuo Z; Chen X; Tomlinson B; Chow MS
    Eur J Pharm Sci; 2010 Feb; 39(4):272-8. PubMed ID: 20060467
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Overview and appraisal of the current concept and technologies for improvement of sublingual drug delivery.
    Wang Z; Chow MS
    Ther Deliv; 2014 Jul; 5(7):807-16. PubMed ID: 25287387
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Recent developments in buccal and sublingual delivery systems.
    Şenel S; Rathbone MJ; Cansız M; Pather I
    Expert Opin Drug Deliv; 2012 Jun; 9(6):615-28. PubMed ID: 22512476
    [TBL] [Abstract][Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.